Appropriate antibacterial therapy is crucial in the management of Pseudomonas aeruginosa infections

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.10, 2007-10, pp. : 14-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pseudomonas aeruginosa Serious Infections: Mono or Combination Antimicrobial Therapy?

Current Medicinal Chemistry, Vol. 15, Iss. 5, 2008-02 ,pp. : 517-522

Bentham Science Publishers

Access to resources Recommend Favorite

Appropriate Empirical Antibacterial Therapy for Nosocomial Infections: Getting it Right the First Time

By Kollef M.H.

Drugs, Vol. 63, Iss. 20, 2003-01 ,pp. : 2157-2168

Adis International

Access to resources Recommend Favorite

Overcoming antibacterial resistance of Pseudomonas aeruginosa

Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Implication of Pseudomonas aeruginosa Biofilms in Infections

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 2, 2011-04 ,pp. : 141-157

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled Tobramycin (TOBI®): A Review of its Use in the Management of Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis

By Cheer S.M. Waugh J. Noble S.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2501-2520

Adis International

Access to resources Recommend Favorite